Procurement and Distribution of Study Medicines

Eric Hardter (), Julia Collins (), Dikla Shmueli-Blumberg () and Gillian Armstrong ()
Additional contact information
Eric Hardter: The Emmes Company, LLC
Julia Collins: The Emmes Company, LLC
Dikla Shmueli-Blumberg: The Emmes Company, LLC
Gillian Armstrong: GSK, Slaoui Center for Vaccines Research

Chapter 11 in Principles and Practice of Clinical Trials, 2022, pp 169-189 from Springer

Abstract: Abstract When compared to clinical trials involving a new (unapproved for human use) drug or biologic, utilizing an approved, commercially available medication in a clinical trial can introduce a new set of variables surrounding procurement and distribution, all of which are fundamental to successful trial implementation. Numerous procurement factors must be considered, including the identification of a suitable vendor, manufacturing of a matching placebo, and expiration dating, all of which can become more intricate when the study increases in complexity by involving factors like active comparators, drug tapering regimens, and research sites in more than one country. Distribution is a similarly complex operation, which involves adherence to regulatory requirements and consideration of aspects such as blinded study designs or utilization of additional safeguards with the use of controlled substances. This chapter will review the basic factors to be taken into consideration during the planning and operational stages of a clinical trial involving a marketed medication and provide examples of how to manage these factors, all of which are aimed at ensuring compliance with both applicable local and international laws and with guidance documents aimed at protecting the rights, safety, and well-being of trial participants.

Keywords: Investigational product (IP); Placebo; Current Good Manufacturing Practices (cGMPs); Blinded/blinding; Manipulation; Procurement; Controlled substance; Vendor; Accountability; Distribution (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-52636-2_34

Ordering information: This item can be ordered from
http://www.springer.com/9783319526362

DOI: 10.1007/978-3-319-52636-2_34

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().